New CEO for Inspyr Therapeutics
August 04, 2016
Inspyr Therapeutics, Inc. (San Antonio, TX) has appointed Christopher Lowe as President and Chief Executive Officer, and as a member of the Company’s Board of Directors. Mr. Lowe brings more than 15 years of executive management experience in life sciences as CEO, Chief Financial Officer and Chief Business Officer, and has been an advisor to the Inspyr’s Board of Directors since March 2016.
Recent Videos
Related Content
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025Article
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
